CorMedix
Price & Volume
Stats
See more52W Range | $2.89-$13.85 |
Market Cap | $515.7M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $12.2M |
Revenue Growth (YoY) | -47.3% |
Gross Profit (12 Mos) | $61,674 |
Diluted EPS | -$0.80 |
News
See moreYahoo Finance • last year
CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
Yahoo Finance • last year
CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023
Yahoo Finance • last year
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
About
CEO | Mr. Joseph Todisco MBA |
CFO | Dr. Matthew T. David M.D. |
Address | 300 Connell Drive, Berkeley Heights, NJ, United States, 07922 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 82 |
